The impact of the Uighur medicine abnormal savda munziq on antitumor and antioxidant activity in a S180 and Ehrlich ascites carcinoma mouse tumor model

Pharmacognosy Magazine

Volumn 8, Issue 30, 2012, Pages 141-148

  Aikemu, Ainiwaer ^a   Yusup, Abdiryim ^a   Umar, Anwar ^a,b   Berké, Bénédicte ^a,b   Moore, Nicholas ^a,b   Upur, Halmurat ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Abnormal savda munziq; antioxidant; antitumor

Indexed keywords

ABNORMAL SAVDA MUNZIQ; CATALASE; CYCLOPHOSPHAMIDE; GLUTATHIONE PEROXIDASE; HERBACEOUS AGENT; MALONALDEHYDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VERAPAMIL;

ADIANTUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INHIBITION; CHINESE HERB; CHINESE MEDICINE; CLIMBING; CONTROLLED STUDY; CORDIA; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; ENZYME BLOOD LEVEL; EUPHORBIA; FEMALE; FOENICULUM; GLYCYRRHIZA URALENSIS; HYPOXIA; JUJUBE; LAVENDER; LOW DRUG DOSE; MALE; MELISSA OFFICINALIS; MOUSE; NONHUMAN; ORGAN WEIGHT; OUTCOME ASSESSMENT; SURVIVAL TIME; TUMOR GROWTH; TUMOR MODEL;

EID: 84861654464     PISSN: 09731296     EISSN: 09764062     Source Type: Journal    
DOI: 10.4103/0973-1296.96568     Document Type: Article

References (20)

1. Yusup A, Upur H, Baudrimont I, Umar A, Kader T, Begaud B, et al. Cytotoxicity of abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells. Fundam Clin Pharmacol 2005;19:465-72. (Pubitemid 41002417)
2. Upur H, Yusup A, Umar A, Moore N. Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda. Therapie 2004;59:483-4. (Pubitemid 39486881)
3. Yusup A, Upur H, Umar A, Moore N. Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damage. Fundam Clin Pharmacol 2004;18:471-6. (Pubitemid 39215360)
4. Abudureyimu H. Antioxidant Effects of Munziq and Mushil of Abnormal Savda by Electron Paramagnetic Resonance. J Tradit Chin Drug Res Clin Pharmacol 2001;6:420-2.
5. Chen Y, Li L, Wu G. Effect of Abnormal Savda Munziq and Mushil on the expression of nuclear factor induced by hydrogen peroxide in lymphocytes. J Xinjiang Med Univ 2005;4:290-2.
6. Yusup A, Upur H, Tursun X, Berke B, Baudrimont, Moore N. [Study on mechanism of abnormal savda munziq flavonoids in induction of apoptosis of Hep2 cells]. Zhongguo Zhong Yao Za Zhi 2007;32:1068-71.
7. Amat N, Upur H, Ablimit A, Matsidik A, Yusup A, Kijjoa A. Immunomodulatory effects of Abnormal Savda Munsiq, a traditional Uighur medicine, on the combined stress mice. J Ethnopharmacol 2009;122:42-7.
8. Yusup A, Upur H, Umar A, Berke B, Yimit D, Lapham JC, et al. Abnormal Savda Munziq. An Herbal Preparation of Traditional Uighur Medicine, may Prevent 1, 2-dimethylhydrazine-induced Rat Colon Carcinogenesis. Evid Based Complement Alternat Med 2009. [In Press]
9. Stolze K, Ablimit A, Strasser A. Effects on cell proliferation and EPR spin trapping studies of Abnormal Savda Munziq and its chromatographic subfractions. BMC Pharmacol 2010;10:A14.
10. Inal ME, Kanbak G, Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta 2001;305:75-80. (Pubitemid 32201964)
11. Andersen HR, Nielsen JB, Nielsen F, Grandjean P. Antioxidative enzyme activities in human erythrocytes. Clin Chem 1997;43:562-8. (Pubitemid 27155037)
12. Gupta V, Lahiri SS, Sultana S, Tulsawani RK, Kumar R. Antioxidative effect of Rhodiola imbricata root extract in rats during cold, hypoxia and restraint (C-H-R) exposure and post-stress recovery. Food Chem Toxicol 2010;48:1019-25.
13. Ku SK, Seo BI, Park JH, Park GY, Seo YB, Kim JS, et al. Effect of Lonicerae Flos extracts on reflux esophagitis with antioxidant activity. World J Gastroenterol 2009;15:4799-805.
14. Salo DC, Lin SW. Pacifici RE, Davies KJ. Superoxide dismutase is preferentially degraded by a proteolytic system from red blood cells following oxidative modification by hydrogen peroxide. Free Radic Biol Med 1988;5:335-9. (Pubitemid 19024283)
15. Kuloglu M, Ustandag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 2002;20:171-5.
16. Ozbay B, Dülger H. Lipid peroxidation and antioxidant enzymes in Turkish population: relation to age, gender, exercise, and smoking. Tohoku J Exp Med 2002;197:119-24.
17. Ni HC, Li J, Jin Y, Zang HM, Peng. The experimental animal model of hyperlipidemia and Hyperlipidemic fatty liver in rats. Chin Pharmacol Bull 2004;20:703-6. (Pubitemid 39071287)
18. Prass K, Scharff A, Ruscher K, Löwl D, Muselmann C, Victorov I, et al. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 2003;34:1981-6. (Pubitemid 36944794)
19. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002;22:393-403. (Pubitemid 34273595)
20. Barker JN. Role of hemoglobin affinity and concentration in determining hypoxia tolerance of mammals during infancy, hypoxia, hyperoxia and irradiation. Am J Physiol 1957;189: 281-9.